Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2005
06/09/2005WO2005051905A2 Large-area two-dimensional non-adhesive cell arrays for sensing and cell-sorting applications
06/09/2005WO2005051700A1 Vehicle sobriety interlock device
06/09/2005WO2005051662A2 Methods for detecting l-ficolin dependent activation of the lectin pathway of complement and kits therefor
06/09/2005WO2005051524A1 Method and device for separation and collection
06/09/2005WO2005051434A1 Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
06/09/2005WO2005051424A1 Targeting of erb antigens
06/09/2005WO2005051423A2 Methods and agents for immune modulation and methods for identifying immune modulators
06/09/2005WO2005051420A1 Novel immunogenic peptide and novel epitopes and the use thereof for producing active pharmaceutical compositions against a hepatitis c virus
06/09/2005WO2005051415A1 Method for preventing and treating diabetes using neurturin
06/09/2005WO2005051413A2 Disease associated genes
06/09/2005WO2005051408A1 Method for preventing and treating diabetes using dg119
06/09/2005WO2005051320A2 Gcks as modifiers of branching morphogenesis and methods of use
06/09/2005WO2005051319A2 Plks as modifiers of the beta catenin pathway and methods of use
06/09/2005WO2005051314A2 Iraks as modifiers of branching morphogenesis and methods of use
06/09/2005WO2005051295A2 Asymmetrically branched polymer conjugates and microarray assays
06/09/2005WO2005051178A2 Marker for neuromyelitis optica
06/09/2005WO2005041758A9 Novel cell-based assays employing voltage and calcium dyes
06/09/2005WO2005040818A3 Diagnostics and therapeutics for diseases associated with organic cation transporter flipt1 (flipt1)
06/09/2005WO2005037859A9 Fluorescence assay for kinase activity
06/09/2005WO2005036175A3 Sensors employing combinatorial artificial receptors
06/09/2005WO2005031003A9 Mutations in wnt-frizzled signaling pathways associated with osteoarthritis
06/09/2005WO2005029072A8 A detection method of hla complement dependent cytotoxic antibodies based on enzyme-linked immunosorbent assay and the kit thereof
06/09/2005WO2005028499A3 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom
06/09/2005WO2005024386A3 Use of photopolymerization for amplification and detection of a molecular recognition event
06/09/2005WO2005024382A9 Nanodevices employing combinatorial artificial receptors
06/09/2005WO2005021728A3 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
06/09/2005WO2005019470A3 Detecting and profiling molecular complexes
06/09/2005WO2005015206A3 Secreted polypeptide species associated with cardiovascular disorders
06/09/2005WO2005011474A3 Multiple high-resolution serum proteomic features for ovarian cancer detection
06/09/2005WO2005010207A3 Methods and compositions for the detection of microbial contaminants
06/09/2005WO2005008248A3 Diagnosis and treatment of cervical cancer
06/09/2005WO2005007891A3 Variants of human taste receptor genes
06/09/2005WO2005003777A3 Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences
06/09/2005WO2005003314A3 A method of selecting an active oligonucleotide predictive model
06/09/2005WO2005002513A3 C1q complement inhibitors and methods of use thereof
06/09/2005WO2004114191A3 Method and apparatus for object based biological information, manipulation and management
06/09/2005WO2004110345A3 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
06/09/2005WO2004110246A3 Methods and compositions for diagnosing conditions associated with specific dna methylation patterns
06/09/2005WO2004110243A3 COMPOSITIONS AND METHODS FOR ENHANCING THE IDENTIFICATION OF PRION PROTEIN PRPsc
06/09/2005WO2004108756A3 Sars coronavirus peptides and uses thereof
06/09/2005WO2004107618A9 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof
06/09/2005WO2004106921A3 In vitro platform for screening agents inducing islet cell neogenesis
06/09/2005WO2004104596A3 Diagnostics and therapeutics for diseases associated with igs70 (igs70)
06/09/2005WO2004104215A3 Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase 7 (dpp7)
06/09/2005WO2004104171A3 Ranbp2 as modifier of the pten/igf pathway and methods of use
06/09/2005WO2004104170A3 Tools for detecting moraxella catarrhalis.
06/09/2005WO2004101743A3 Three dimensional cell cultures in a microscale fluid handling system
06/09/2005WO2004099937A3 Microarray dispensing with real-time verification and inspection
06/09/2005WO2004099307A3 Nanocylinder-modified surfaces
06/09/2005WO2004098628A3 Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
06/09/2005WO2004097405A3 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor h7tba62 (h7tba62)
06/09/2005WO2004092336A3 Fragments of fluorescent proteins for protein fragment complementation assays
06/09/2005WO2004089184A3 NEW USES OF Lp-PLA2 IN COMBINATION TO ASSESS CORONARY RISK
06/09/2005WO2004086027A3 Mechanical resonator
06/09/2005WO2004081177A3 Intracellular signaling pathways in diabetic subjects
06/09/2005WO2004080615A3 Apparatus for detecting and reporting environmental conditions in bulk processing and handling of goods
06/09/2005WO2004076646A3 Methods and compositions for treating cervical cancer
06/09/2005WO2004074781A3 Method and apparatus for measuring dry density and water content of soil
06/09/2005WO2004069736A3 Articles with protruding conductive coatings
06/09/2005WO2004050830A3 Methods for covalently attaching proteins to substrates
06/09/2005WO2004043383A8 A new target for angiogenesis and anti-angiogenesis therapy
06/09/2005WO2004040298A3 Tumor marker proteins for diagnosis and therapy of cancer and cancer risk assessment
06/09/2005WO2004015427A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 19 (gpr19)
06/09/2005WO2003073355A3 Method and apparatus for generating chemical reaction transforms
06/09/2005WO2003072023A3 Novel compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer
06/09/2005US20050125851 Methods of diagnosis and treatment of interstitial lung disease
06/09/2005US20050125201 Data analyzer
06/09/2005US20050125186 Biometric quality control process
06/09/2005US20050125161 Differentially-expressed conifer cDNAs, and their use in improving somatic embryogenesis
06/09/2005US20050125159 Methods for analyzing biological elements
06/09/2005US20050124979 Miniaturized device; substrate with reservoirs; aperture; barrier covering; sustained release
06/09/2005US20050124909 Body fat measuring device
06/09/2005US20050124870 Measuring analytes from an electromagnetic spectrum using a wavelength router
06/09/2005US20050124868 Blood sugar level measuring apparatus
06/09/2005US20050124800 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells
06/09/2005US20050124796 Mouse cytokine receptor
06/09/2005US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor
06/09/2005US20050124794 Histidine-proline rich tropomyosin-related anti-angiogenic receptor polypeptide or peptide tor use in prevention and treatment of tumor
06/09/2005US20050124789 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/09/2005US20050124653 Prevention of cancer using chloroquinine compound; side effect reduction
06/09/2005US20050124645 Methods and compositions for increasing CD4lymphocyte immune responsiveness
06/09/2005US20050124585 Which contain phosphoramidate linkages; for retroviral or hepadnaviral therapy; for treatment of HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability
06/09/2005US20050124584 Prodrugs of phosphonate nucleotide analogues
06/09/2005US20050124583 Prodrugs of phosphonate nucleotide analogues
06/09/2005US20050124556 an indoxyl beta-D-ribofuranoside chromogenic substrate for detecting beta-D-ribofuranosidase activity; synthesis by r3eacting a ribofuranosyl trichloroacetimidate with an N-protected 3-hydroxyindole compound
06/09/2005US20050124549 Method of modulating the proliferation of medullary thyroid carcinoma cells
06/09/2005US20050124540 Antigens; induce immunology response; neutralizaton antibodies; prevent infections; diagnosis
06/09/2005US20050124077 Diagnostic testing process and apparatus
06/09/2005US20050124076 Method for screening autoantigen
06/09/2005US20050124072 Personal care products with visual indicator of vaginitis
06/09/2005US20050124071 Methods and compositions for diagnosing musculoskeletal, arthritic and joint disorders by biomarker dating
06/09/2005US20050124060 Enzyme activity measuring apparatus, enzyme activity measuring method, sample transcription apparatus and color measuring apparatus
06/09/2005US20050124058 System for housing/processing carrier and method for housing/processing carrier
06/09/2005US20050124056 For diagnosing rheumatoid arthritis
06/09/2005US20050124039 Mixing cationic lipid with a polynucleotide, coding for antigenic determinant, thereby forming a cationic lipid-polynucleotide complex; administering complex to animal for eliciting an immune response
06/09/2005US20050124027 Method for recovering microorganisms from a sample
06/09/2005US20050124026 Detecting staphylococcus in blood products; immunoassay
06/09/2005US20050124024 contacting the solubilized p-nitrophenyl phosphate with charcoal, a buffered solution of phenyl phosphate can be provided with super stability
06/09/2005US20050124019 Reagent-containing membranes and laminates and methods of their preparation
06/09/2005US20050124018 Method of measuring ATP by radiating ultraviolet light and apparatus using the same